APA (7th ed.) Citation

Sakaguchi, T., Iketani, A., Esumi, S., Esumi, M., Suzuki, Y., Ito, K., . . . Hataji, O. (2023). Clinical importance of the range of detectable variants between the Oncomine Dx target test and a conventional single-gene test for EGFR mutation. Scientific Reports, 13(1), . https://doi.org/10.1038/s41598-023-40271-w

Chicago Style (17th ed.) Citation

Sakaguchi, Tadashi, et al. "Clinical Importance of the Range of Detectable Variants Between the Oncomine Dx Target Test and a Conventional Single-gene Test for EGFR Mutation." Scientific Reports 13, no. 1 (2023). https://doi.org/10.1038/s41598-023-40271-w.

MLA (9th ed.) Citation

Sakaguchi, Tadashi, et al. "Clinical Importance of the Range of Detectable Variants Between the Oncomine Dx Target Test and a Conventional Single-gene Test for EGFR Mutation." Scientific Reports, vol. 13, no. 1, 2023, https://doi.org/10.1038/s41598-023-40271-w.